Phreesia Pre-Tax Profit Margin 2019-2025 | PHR
Phreesia pre-tax profit margin from 2019 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Phreesia Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-07-31 | $0.45B | $-0.02B | -5.11% |
| 2025-04-30 | $0.44B | $-0.04B | -8.97% |
| 2025-01-31 | $0.42B | $-0.06B | -13.10% |
| 2024-10-31 | $0.41B | $-0.08B | -19.75% |
| 2024-07-31 | $0.39B | $-0.10B | -25.13% |
| 2024-04-30 | $0.37B | $-0.12B | -31.28% |
| 2024-01-31 | $0.36B | $-0.14B | -37.82% |
| 2023-10-31 | $0.34B | $-0.14B | -42.18% |
| 2023-07-31 | $0.32B | $-0.15B | -47.19% |
| 2023-04-30 | $0.30B | $-0.16B | -53.64% |
| 2023-01-31 | $0.28B | $-0.18B | -62.63% |
| 2022-10-31 | $0.26B | $-0.19B | -70.61% |
| 2022-07-31 | $0.25B | $-0.18B | -73.88% |
| 2022-04-30 | $0.23B | $-0.16B | -69.30% |
| 2022-01-31 | $0.21B | $-0.12B | -55.40% |
| 2021-10-31 | $0.20B | $-0.08B | -40.10% |
| 2021-07-31 | $0.18B | $-0.05B | -27.93% |
| 2021-04-30 | $0.16B | $-0.03B | -19.63% |
| 2021-01-31 | $0.15B | $-0.03B | -18.24% |
| 2020-10-31 | $0.14B | $-0.03B | -17.99% |
| 2020-07-31 | $0.13B | $-0.02B | -14.93% |
| 2020-04-30 | $0.13B | $-0.02B | -16.15% |
| 2020-01-31 | $0.13B | $-0.02B | -17.60% |
| 2019-07-31 | $0.08B | $-0.02B | -21.43% |
| 2019-04-30 | $0.08B | $-0.01B | -17.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.350B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.812B | 58.34 |
| Tempus AI (TEM) | United States | $11.803B | 0.00 |
| Doximity (DOCS) | United States | $9.361B | 38.54 |
| Hims & Hers Health (HIMS) | United States | $8.207B | 66.76 |
| IRhythm Technologies (IRTC) | United States | $5.429B | 0.00 |
| Hinge Health (HNGE) | United States | $3.287B | 0.00 |
| Privia Health (PRVA) | United States | $2.921B | 182.69 |
| Heartflow (HTFL) | United States | $2.635B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.522B | 41.72 |
| 10x Genomics (TXG) | United States | $2.035B | 0.00 |
| Enovis (ENOV) | United States | $1.765B | 9.27 |
| Omnicell (OMCL) | United States | $1.596B | 32.62 |
| Azenta (AZTA) | United States | $1.370B | 59.76 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Schrodinger (SDGR) | United States | $1.267B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.915B | 0.00 |
| Claritev (CTEV) | United States | $0.730B | 0.00 |
| Talkspace (TALK) | United States | $0.535B | 107.67 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.523B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Standard BioTools (LAB) | United States | $0.461B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.365B | 0.00 |
| Carlsmed (CARL) | United States | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.08 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| CapsoVision (CV) | United States | $0.265B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.225B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.188B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.181B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.166B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 7.40 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.066B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |